Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

M&A · Partnership
โดย GHO Capital·Read original
Summary · why it matters

Excellere Partners and GHO Capital have completed the sale of Biocare Medical to Agilent Technologies. Under their ownership, Biocare achieved annual double-digit revenue and profitability growth, strengthened its core immunohistochemistry business, expanded into molecular diagnostics through acquisition, and reinforced its executive leadership team. The acquisition combines two businesses with closely aligned strategies in life sciences and diagnostics, expected to unlock greater market access, enhanced customer support, and accelerated innovation for Biocare's customers worldwide.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
Agilent Technologies Inc
A
▲ PositiveCapitalrelevance

Agilent completes acquisition of Biocare Medical, expanding its diagnostics portfolio.

Off-coverage companies 2

Excellere PartnersPrivate▲ Positive
Capitalrelevance

Excellere Partners successfully exits Biocare Medical, realizing returns from its investment.

GHO Capital Partners LLPPrivate▲ Positive
Capitalrelevance

GHO Capital successfully exits Biocare Medical, realizing returns from its investment.

© 2026 MarketDXNews